Views 267
Citations 0
Comment & Response
May 3, 2016

Noninvasive Ventilation and Outcomes Among Immunocompromised Patients

Author Affiliations
  • 1Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy
  • 2Department of Biopathology and Medical Biotechnologies, University of Palermo, Palermo, Italy
  • 3Department of Anesthesiology and Intensive Care Medicine, Università Cattolica del Sacro Cuore, Rome, Italy

Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA. 2016;315(17):1902. doi:10.1001/jama.2016.0677

To the Editor Dr Lemiale and colleagues1 found that early noninvasive ventilation compared with oxygen therapy alone did not reduce intubation rate and 28-day mortality in immunosuppressed patients with hypoxemic acute respiratory failure. The study has important limitations that the authors acknowledged only in part.

There are at least 3 major methodological limitations in addition to the 2 already recognized by the authors (ie, the lower-than-expected mortality rate, making the study likely underpowered, and the significantly higher proportion of patients receiving high-flow nasal oxygen in the control group, limiting the ability to detect the potential benefit of noninvasive ventilation).2

First Page Preview View Large
First page PDF preview
First page PDF preview